Mouth occlusion pressure at 100ms (P0.1) as a respiratory biomarker in amyotrophic lateral sclerosis
Volume 22, Issue 1-2, February 2021, Page 53-60
.
Related Articles
Modelling the cascade of biomarker changes in GRN-related frontotemporal dementia
Objective Progranulin-related frontotemporal dementia (FTD-GRN) is a fast progressive disease. Modelling the cascade of multimodal biomarker changes aids in understanding the aetiology of this disease…
Reconsidering the revised amyotrophic lateral sclerosis functional rating scale for ALS clinical trials
Introduction Clinical trials in amyotrophic lateral sclerosis (ALS) aim to identify treatments that can slow functional decline or prolong survival time. In the absence of…
Ratio of urinary N-terminal titin fragment to urinary creatinine is a novel biomarker for amyotrophic lateral sclerosis
Objective We aimed to investigate the validity of urinary N-terminal titin fragment as a biomarker for amyotrophic lateral sclerosis (ALS). Methods We consecutively enrolled patients…
A patient with papilloedema
CASE DESCRIPTION A 45-year-old Jordanian man had 2 weeks of gradual onset headache, neck stiffness and loss of vision. The headache was occipital with pulsatile tinnitus…
Pre-diagnostic plasma lipid levels and the risk of amyotrophic lateral sclerosis
Volume 22, Issue 1-2, February 2021, Page 133-143. Read article in journal’s website
English
العربية
简体中文
Nederlands
Français
Deutsch
Italiano
Português
Русский
Español
Responses